THE HEALTH CARE SYSTEM IN NORTHERN IRELAND
The Northern Ireland Health Service (NHS) is available to all citizens and is government funded. Although a small number of patients have additional private healthcare plans, the NHS is the major provider of free health care services. The service is available through general practitioners that provide primary care to a network of district and regional hospitals. The NHS is funded through an individual system of general tax contributions.
Provision of cancer services
Cancer genetics services in Northern Ireland, as in the rest of the UK, are modelled on the "Calman" system [1, 2] . This is arranged in a three level provider service as follows:
Level 1 Primary Care: This level is provided by general practitioners (GP) with access to local routine consultation and screening for low risk patients. GP's act as gatekeepers for access and referral to specialist hospital practitioners for further screening and investigation. 
THE NORTHERN IRELAND GENETIC SERVICE
Current genetics services in the United Kingdom are organized on a regional basis with staffing ratio of 1 consultant geneticist per 500,000 population [3] . In Northern Ireland the service was established in 1967 by Professor NC Nevin. It is based in Belfast City Hospital with responsibility for providing regional genetic counselling and diagnostic clinics and laboratory services in all areas of Northern Ireland. The Cancer genetics services started in 1989, initially from a research interest in multiple endocrine neoplasia, and other rare familial cancers. Clinical research and services have expanded, and since 1995, direct mutation testing was introduced for MEN types 2A, 2B and FMTC (familial medullary thyroid cancer). In 1996, mutational analysis for familial adenomatous polyposis cancer was introduced, and subsequently for BRCA1 and BRCA 2 and bowel cancers (HNPCC). The funding for the molecular tests for cancer is from research grants. Since 1999, the regional molecular genetics laboratory, part of the Northern Ireland Regional Genetics Service, based in Belfast City Hospital offers a range of service tests, including FAP, 
Communication of results
Results are discussed with the patient and family by the clinical geneticist and a written report is provided to the patient and appropriate medical personnel. Clinical surveillance, according to national guidelines, is arranged for patients with a high risk and for mutation carriers for bowel and breast cancer.
Staffing
There is 1 full time genetic nurse who undertakes pre-clinic visits at which she obtains a full family history, clinical details and obtains pathological confirmation (0.3 "Whole Time Equivalent" WTE cancer genetics). A Consultant and Senior registrar contribute 0.5 WTE each to the cancer genetics clinics. There are proposals for a consultant clinical geneticist with a special interest in cancer genetics to cope with increasing demand for this service, with appropriate secretarial, data manager and junior clinical staff support. The current funding of the cancer genetics clinics is from research/charity sources and ad hoc NHS funding. It is proposed that additional service cytogenetic and molecular genetic laboratory staff will be funded through the NHS.
Audit of services
All cancer genetic clinics are subject to continuing audit and evaluation of service. Other potentially autosomal dominant childhood cancers -Retinoblastoma, Wilm's tumour, Ataxia telangiectasia, aniridia.
Any cancer family history with significant patient concern
Breast cancer risk:
The population risk of breast cancer in Northern Ireland is 1 in 12. Medium risk defined as 1 in 6, to 1 in 4. High risk defined as _ 1 in 4.
